KURE Among China ETFs
End-of-day Nov 13, 2026 · 24 China ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −3.6% | +1.2% | −2.6% | +6.3% | −2.9% | +1.9% | −35.4% | −10.6% |
| Peer average | −0.8% | −3.6% | −4.8% | −14.8% | −15.3% | −18.2% | +17.5% | −25.1% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$96 of every $1,000 in KURE is Beone
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 6160.HKBeone Medicines | Healthcare | 9.64% | $964.32 | 342K | $11.0M |
| 2 | 1801.HKInnovent Biologics | Healthcare | 8.14% | $813.51 | 837K | $9.3M |
| 3 | 2269.HKWuxi Biologics Cayman | Healthcare | 7.56% | $755.94 | 1.4M | $8.6M |
| 4 | 603259.SSWuxi Apptec | Healthcare | 5.54% | $553.86 | 283K | $6.3M |
| 5 | 600276.SSJiangsu Hengrui Pharmaceut | Healthcare | 4.48% | $447.68 | 705K | $5.1M |
| 6 | 300760.SZShenzhen Mindray Bio-medic | Healthcare | 4.30% | $430.48 | 185K | $4.9M |
| 7 | 9926.HKAkeso | Healthcare | 4.15% | $414.69 | 418K | $4.7M |
| 8 | 1177.HKSino Biopharmaceutical | Healthcare | 3.91% | $390.51 | 6.3M | $4.4M |
| 9 | 1093.HKCspc Pharmaceutical Group LT | Healthcare | 3.47% | $347.37 | 3.6M | $4.0M |
| 10 | 2359.HKWuxi Apptec -H | Healthcare | 3.19% | $319.39 | 145K | $3.6M |
| 11 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.09% | $308.56 | 802K | $3.5M |
| 12 | 1548.HKGenscript Biotech | Healthcare | 2.80% | $280.08 | 720K | $3.2M |
| 13 | 000538.SZYunnan Baiyao Group | Healthcare | 2.42% | $242.36 | 339K | $2.8M |
| 14 | 688271.SSShanghai United Imaging He | Healthcare | 2.41% | $240.63 | 157K | $2.7M |
| 15 | 1530.HK3sbio | Healthcare | 2.11% | $210.62 | 1.3M | $2.4M |
Every fund here earned less than cash (3.8%) over the past year; the bars still rank them by return for the bumps.
of the $19.0B in 24 China ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 6160.HK | Beone Medicines | 9.64% |
| 2 | 1801.HK | Innovent Biologics | 8.14% |
| 3 | 2269.HK | Wuxi Biologics Cayman | 7.56% |
| 4 | 603259.SS | Wuxi Apptec -A | 5.54% |
| 5 | 600276.SS | Jiangsu Hengrui Pharmaceut-a | 4.48% |
| 6 | 300760.SZ | Shenzhen Mindray Bio-medic-a | 4.30% |
| 7 | 9926.HK | Akeso | 4.15% |
| 8 | 1177.HK | Sino Biopharmaceutical | 3.91% |
| 9 | 1093.HK | Cspc Pharmaceutical Group LT | 3.47% |
| 10 | 2359.HK | Wuxi Apptec -H | 3.19% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.0104 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.0001 |
| Dec 27, 2019 | Dec 31, 2019 | $0.0573 |
| Dec 26, 2018 | Dec 28, 2018 | $0.0760 |